BD (NYSE: BDX) shares dipped before hours today despite first-quarter results that came in ahead of the consensus Wall Street ...

Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...

A once-popular restaurant chain known for its Asian-fusion dishes and make-your-own stir fry bowls has closed its last location in the state after launching in metro Detroit more than 30 years ago.

Company’s latest solutions are designed to empower healthcare providers across the Middle East region, strengthen patient ...

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be reporting results this Monday before the bell. Here’s what to expect.

BD (BD) stock dips despite beating the consensus with its Q1 FY26 financials as its Life Sciences unit trailed estimates. Read more here.

As the market for GLP-1 injections continues to grow, BD aims to ride that wave by providing drugmakers with its prefilled syringes. Biologic medications—including those blockbusters for diabetes and ...

In its Q1 fiscal 2026 financials, BD trimmed its EPS outlook by more than $2 at the high end due to the spin-off of its ...